Prevalence has previously been controversial, with contradictory reports from studies reporting either very low prevalence, or a high prevalence. With the increasing availability of screening mammography, however,<unk> s are being diagnosed earlier, and more recent studies suggest<unk> s represent between 8% and 27% of all breast cancers.
Tubular carcinoma
Clear-cell ovarian carcinoma
Microcystic adnexal carcinoma
Eccrine carcinoma
Uterine clear-cell carcinoma
Stromal tumor
Ovarian fibroma
Papillary serous cystadenocarcinoma